证券日报网讯 8月29日晚间，南京医药发布公告称，2025年半年度公司实现营业收入27，967，411， 701.62元，同比增长2.70%；归属于上市公司股东的净利润为291，276，712.36元，同比下降6.44%。 （编辑 何成浩） ...

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first half of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first half of 2025 was 9.699 billion yuan, representing a year-on-year decrease of 24.45% [1] - The net profit attributable to shareholders of the listed company was 107 million yuan, down 36.24% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 96.2624 million yuan, a decrease of 9.84% year-on-year [1] - The basic earnings per share were 0.37 yuan [1]

Group 1 - The core viewpoint of the article is that Guoyao Yicai (000028.SZ) reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] - The company achieved operating revenue of 36.797 billion yuan, a year-on-year decrease of 2.62% [1] - The net profit attributable to shareholders was 666 million yuan, reflecting a year-on-year decline of 10.43% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 643 million yuan, down 9.63% year-on-year [1] - The basic earnings per share were reported at 1.2 yuan [1]

（文章来源：证券日报） 证券日报网讯 8月29日晚间，南京医药发布公告称，公司第十届董事会第三次会议审议通过了《南京医 药股份有限公司2025年半年度报告》及其摘要等多项议案。 ...

智通财经APP讯，南京医药(600713.SH)披露2025年半年度报告，报告期公司实现营收279.67亿元，同比 增长2.70%;归母净利润2.91亿元，同比下降6.44%;扣非净利润2.62亿元，同比下降14.08%;基本每股收益 0.222元。公司拟向全体股东每10股派发现金红利1.70元(含税)。 ...

（原标题：南京医药(600713.SH)发布半年度业绩，归母净利润2.91亿元，同比下降6.44%） 智通财经APP讯，南京医药(600713.SH)披露2025年半年度报告，报告期公司实现营收279.67亿元，同比 增长2.70%;归母净利润2.91亿元，同比下降6.44%;扣非净利润2.62亿元，同比下降14.08%;基本每股收益 0.222元。公司拟向全体股东每10股派发现金红利1.70元(含税)。 ...

Group 1 - The company, Jia Shi Tang, reported a revenue of 9.699 billion yuan for the first half of 2025, representing a year-on-year decrease of 24.45% [1] - The net profit attributable to shareholders of the listed company was 107 million yuan, down 36.24% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 96.2624 million yuan, a year-on-year decline of 9.84% [1] - The basic earnings per share were 0.37 yuan [1]

嘉事堂8月29日披露半年报，公司上半年实现营业收入96.99亿元，同比下降24.45%；归属于上市公司股 东的净利润1.07亿元，同比下降36.24%；基本每股收益0.37元。 ...

Core Viewpoint - The company reported a decline in both revenue and net profit for the first half of the year, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 36.797 billion yuan, a year-on-year decrease of 2.62% [1] - The net profit attributable to shareholders was 666 million yuan, reflecting a year-on-year decline of 10.43% [1] - The basic earnings per share were reported at 1.2 yuan [1]

证券日报网讯 8月29日晚间，南京医药发布公告称，公司第十届监事会第二次会议审议通过了《南京医 药股份有限公司2025年半年度报告》及其摘要等多项议案。 （文章来源：证券日报） ...